Dark

EYEG
AB Corporate Bond ETF
stock NASDAQ ETF

Market Open

Jan 21, 2026 12:16:26 PM EST

35.75USD-0.223%(+35.75)207

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD0.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

28.77M

Headquarters

MA, USA

Industry

Biotechnology

Last Dividend

Sep 2, 20250.142

Last Split

Aug 30, 20191for15reverse

FLKS MYOS KALV SNOA XLV

EYEG Stats

Avg. Vol. 10 Day

560

Avg. Vol. 30 Day

4,505

Employees

Market Cap

28,768,000

Shares Out.

800,000

On/Off Exchange

33%/67%

6 Month Beta

0.10

1 Year Beta

0.10

2 Year Beta

0.10

3 Year Beta

0.10

52 Week Low

33.92

52 Week High

36.63

SMA50

35.91

SMA200

35.63

1 Week

+0.83%

1 Month

-0.18%

3 Month

-1.70%

6 Month

+1.22%

1 Year

+1.88%

2 Year

+1.03%

5 Year

+438.32%

Profile

Eyegate Pharmaceuticals Inc focuses on developing and commercializing products for treating diseases and disorders of the eye.

EYEG Stock Summary

AB Corporate Bond ETF (NASDAQ:EYEG) stock price today is $35.75, and today's volume is 207. EYEG is down -0.223% today. The 30 day average volume is 4,505. EYEG market cap is 28.77M with 800,000 shares outstanding.

.dark-mode .tHqtPr{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .tHqtPr{ color: #333333; background-color: white; border: 2px solid #333333; }EYEGAB Corporate Bond ETFstock NASDAQ ETF

EYEG Stock Summary

EYEG
AB Corporate Bond ETF
stock NASDAQ ETF